Fischer GM, Lamba N, Vogelzang J, Aizer A, et al. Genomic profiling reveals SMARCA4 mutations are associated with shorter overall and intracranial progression free survival in melanoma brain metastasis patients. Clin Cancer Res 2024 Dec 30. doi: 10.1158/1078-0432.CCR-24-0301.
PMID: 39786469